Analysis

Evolus, Inc. Common Stock (EOLS) Stock Analysis

Evolus, Inc. Common Stock investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to EOLS.

websiteEOLS/analysis/EOLS

Evolus, Inc. Common Stock

Evolus, Inc. Common Stock investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to EOLS.

Stock profile

Ticker

EOLS

Asset type

Stock

Market cap

$436.6M

Sector

Health Technology

Industry

Pharmaceuticals: Major

Currency

USD

Ticker listings

Evolus, Inc. Common Stock may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • EOLS primary listing
  • EVL
  • A2JDYX
  • 0K16

Latest Evolus, Inc. Common Stock news

Evolus to Participate in The Jefferies Global Healthcare Conference

Evolus to Participate in The Jefferies Global Healthcare Conference

Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe

NEWPORT BEACH, Calif., May 11, 2026--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today a...

Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirm...

NEWPORT BEACH, Calif., May 04, 2026--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today a...

Evolus to Report First Quarter Financial Results on May 4, 2026

NEWPORT BEACH, Calif., April 14, 2026--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announ...

Telix Appoints David Gill as Non-Executive Director

MELBOURNE, Australia and INDIANAPOLIS, April 02, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces the appointment of David...

Research sections

Valuation

Review valuation context for Evolus, Inc. Common Stock.

Future growth

Review future growth context for Evolus, Inc. Common Stock.

Past performance

Review past performance context for Evolus, Inc. Common Stock.

Financial health

Review financial health context for Evolus, Inc. Common Stock.

Dividend

Review dividend context for Evolus, Inc. Common Stock.

Management

Review management context for Evolus, Inc. Common Stock.

Ownership

Review ownership context for Evolus, Inc. Common Stock.

Other information

Review other information context for Evolus, Inc. Common Stock.

Community

Review community context for Evolus, Inc. Common Stock.